Coinbase adds BIO and EUL to its asset roadmap, how are these tokens performing?

Coinbase has included Bio Protocol and Euler in its asset roadmap, indicating they might be listed on the alternate down the road.

In a July 29 X put up, crypto alternate Coinbase introduced that it has added Bio Protocol (BIO) and Euler (EUL) to its asset roadmap.

Following the announcement, BIO rallied almost 17% earlier than giving up a few of its good points and buying and selling barely decrease on the time of writing.

For the uninitiated, Bio Protocol is the native token powering a decentralized science (DeSci) ecosystem. It permits the creation of community-governed biotech analysis collectives, often called BioDAOs, and helps the tokenization of scientific mental property.

Euler, however, is the governance token for Euler Finance, a permissionless DeFi lending protocol constructed on Ethereum. It permits customers to lend and borrow a variety of crypto belongings, together with long-tailed tokens not sometimes supported by different platforms. EUL has reacted extra modestly, going up simply 3.5% after the announcement.

Each tokens have already secured listings on a number of common cryptocurrency exchanges, akin to Binance, OKX, Kraken, Gate.io, MEXC, KuCoin for Bio Protocol, and Kraken, KuCoin, HTX, Gate.io for Euler.

Nevertheless, traders ought to observe that Coinbase’s asset roadmap solely signifies the cryptocurrencies at present into account for potential itemizing and doesn’t assure that they may in the end be added to the platform.

The Coinbase impact

As a Tier-1 alternate, Coinbase listings usually lead to short-term rallies. Crypto merchants confer with it because the “Coinbase impact.” The momentum stems from the platform’s popularity, broad consumer base, and attraction amongst institutional traders.

Market members are likely to interpret listings as a sign of legitimacy, which regularly results in elevated demand and upward worth stress within the brief time period.

Traditionally, a number of tokens have recorded double-digit intraday good points following a Coinbase announcement or itemizing. 

Nevertheless, whereas preliminary rallies are widespread, they don’t seem to be assured, nor do they at all times maintain over the long run. Market circumstances, token provide dynamics, and broader investor sentiment all play a job in figuring out whether or not the itemizing results in lasting appreciation.

For example, NEWT, the native token of Newton Protocol, crashed 44% shortly after its itemizing on Coinbase. In keeping with a report by crypto.information, the sharp drop was pushed by traders promoting off their airdropped tokens to safe earnings, resulting in heightened promoting stress instantly following the itemizing.

One other instance that underscores this volatility is the case of Venice AI’s token, VVV. Shortly after being listed on Coinbase, the token noticed a pointy preliminary pump. Nevertheless, the rally was short-lived, and the value crashed after studies emerged that the undertaking crew allegedly issued and bought roughly $5.7 million price of VVV tokens across the time of the itemizing.

Since each BIO and EUL are already listed on a number of main exchanges, the impression of a possible Coinbase itemizing might not be as pronounced as it might be for a newly launched token.